Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure

BACKGROUND: Mesenchymal stem cells (MSCs) are a heterogeneous group of subpopulations with differentially expressed surface markers. CD146 + MSCs correlate with high therapeutic and secretory potency. However, their therapeutic efficacy and mechanisms in premature ovarian failure (POF) have not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lin, Sun, Yang, Zhang, Xiao-Xu, Liu, Yu-Bin, Sun, Hui-Yan, Wu, Chu-Tse, Xiao, Feng-Jun, Wang, Li-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209844/
https://www.ncbi.nlm.nih.gov/pubmed/35729643
http://dx.doi.org/10.1186/s13287-022-02916-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209844/
https://www.ncbi.nlm.nih.gov/pubmed/35729643
http://dx.doi.org/10.1186/s13287-022-02916-x

Ejemplares similares